Ezetimibe/Rosuvastatin/Valsartan - LG Chem
Alternative Names: EV-81; LGEV1801/LGEV1802Latest Information Update: 28 Jun 2022
At a glance
- Originator LG Chem
- Class Antihyperlipidaemics; Antihypertensives; Azetidines; Branched-chain amino acids; Fluorobenzenes; Propanols; Pyrimidines; Small molecules; Sulfonamides; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dyslipidaemias; Hypertension
Most Recent Events
- 28 Jun 2022 No recent reports of development identified for preclinical development in Dyslipidaemias in South Korea (PO)
- 28 Jun 2022 No recent reports of development identified for preclinical development in Hypertension in South Korea (PO)
- 22 May 2018 LG Chem plans a phase I trial for Healthy volunteers in South Korea (NCT03532854)